|
Princeton University Invention #
90-0954
The technology
as described in US patent # 5,753,500 relates to a method for producing
substantially pure stocks of recombinant adeno-associated virus, free of the
adeno-associated helper virus found associated with previously available
recombinant AAV. These pure stocks can be used to introduce exogenous...
Published: 3/15/2018
|
Inventor(s): Mark Labow, Stephan Baim, Arnold Levine, Thomas Shenk
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|